HuM&C휴엠앤씨
263920 · KOSDAQ · ₩263920 · 휴엠앤씨
- Market cap
- ₩28B
- Enterprise value
- ₩31B
- P/E
- 8.9×
- P/B
- 0.6×
- Dividend yield
- 6.9%
- ROE
- 7.1%
- Net margin
- 5.6%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−39.8% from the high
₩2,500Today: ₩2,840 – ₩2,900₩4,790
Returns
- 1W−2.2%
- 1M−8.7%
- 3M−22.7%
- 6M−26.9%
- YTD−25.3%
- 1Y−29.1%
- Volume today
- 394
- 0.1× the 20-day average
- Traded today
- ₩1.1M
- Listed shares
- 9,809,026
- EPS (12 months)
- ₩325
- Earnings yield 11.3%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 26 of 100 (50 is a normal day for this stock).
- MomentumWeak-9.1% over the last month; the price is below its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
HuM&C stock overview
HuM&C (휴엠앤씨, KRX: 263920) is listed on KOSDAQ, in the Consumer goods sector. The company makes medical glass containers, including ampoules, vials and cartridges, mainly for pharmaceutical companies' injectable drugs, and also makes glass containers for food and cosmetics. Its shares closed at ₩2,885 on Oct 27, 2026, up 1.58% on the day, giving it a market value of ₩28B.
Key facts
- Market cap
- ₩28B
- Sector
- Consumer goods
- Latest price change
- +1.58%
- As of
- Oct 27, 2026
- Main business
- The company makes medical glass containers, including ampoules, vials and cartridges, mainly for pharmaceutical companies' injectable drugs, and also makes glass containers for food and cosmetics.
Quick answers about HuM&C
- What does HuM&C do?
- The company makes medical glass containers, including ampoules, vials and cartridges, mainly for pharmaceutical companies' injectable drugs, and also makes glass containers for food and cosmetics. It also manufactures and exports cosmetic accessories such as makeup sponges, puffs and containers, selling business-to-business to cosmetics makers, distributors and other suppliers rather than to consumers. Its glass operations serve customers in Korea and abroad, and it has production sites in Nonsan, Korea and Vietnam.
- What is the market cap of HuM&C?
- The market capitalisation of HuM&C was ₩28B at the close on Oct 27, 2026.
- Who are the largest shareholders of HuM&C?
- According to the latest official filings, the largest reported holders are Huons Global (65.02%, as of Mar 16, 2026); Kim Jun-cheol (0.10%, as of Jul 21, 2025); Jeong Jae-hwan (0.08%, as of Nov 20, 2024).
- When is the next earnings report from HuM&C?
- Korean companies rarely announce results dates in advance. Based on when HuM&C filed the same report in past years, its next 3q results is expected between Nov 10, 2026 and Nov 14, 2026.
Company profile
The company makes medical glass containers, including ampoules, vials and cartridges, mainly for pharmaceutical companies' injectable drugs, and also makes glass containers for food and cosmetics. It also manufactures and exports cosmetic accessories such as makeup sponges, puffs and containers, selling business-to-business to cosmetics makers, distributors and other suppliers rather than to consumers. Its glass operations serve customers in Korea and abroad, and it has production sites in Nonsan, Korea and Vietnam.
Written by AI from the company's latest annual report.
- Korean name
- 휴엠앤씨
- Sector
- Consumer goods
- Themes
- —
- CEO
- 이충모
- Founded
- Jun 2002
- Listed
- Sep 2017
- Listed shares
- 9,809,026
- Fiscal year ends
- Month 12
- Website
- humnc.com
Similar companies
- Spigen Korea192440 · ₩173B₩27,850+3.15%
- Novatech285490 · ₩118B₩11,170+0.90%
- Samick Musical Instruments002450 · ₩94B₩1,040+0.78%
- Alux475580 · ₩83B₩6,090+0.16%
- E-World084680 · ₩62B₩2,200+0.92%
- Xplus373200 · ₩60B₩2,400−9.94%
- Envioneer317870 · ₩42B₩4,750+1.93%
- J.Estina026040 · ₩33B₩1,987+2.79%
Recent filings
See all- Half-year report (Jun 2026)Aug 14, 2026
- Trust Contract Termination Result ReportAug 12, 2026
- Material Matters Report (Decision on Termination of Trust Agreement for Own Share Acquisition)Aug 11, 2026
- Progress Update on Embezzlement and Breach of Trust AllegationsJul 3, 2026
- Buyback trust contract signedJun 11, 2026
Titles in Korean until English translations are added.
Also known as: HuM&C / 휴엠앤씨 / 263920 / KRX:263920
Source: KRX statistical information